优先选择全球或全国头部供应商；BONTAC® 全酶法 β-NMN 以 99.9% 纯度与 β 型活性为质量门槛。全球同类先进水平是立项的基本门槛。We prioritize globally or nationally leading suppliers; BONTAC® full-enzymatic β-NMN at 99.9% purity and active β-isomer is our quality baseline. Globally competitive performance is a baseline for product approval.
核对配方与原料 →Inspect formula & materials →
产品与包装Product & package
基础款 · 单一成分 · NAD⁺ 日常支持CORE · single ingredient · everyday NAD⁺ support
高纯基础 NMNNMN Pure
每粒 500 mg BONTAC® 全酶法 β-NMN，99.9% 纯度；每瓶 120 粒、标示总量 60,000 mg。单一活性成分、剂量完整公开——成分、证据边界与批次报告，都可以继续往下核对。 500 mg BONTAC® full-enzymatic β-NMN per capsule at 99.9% purity; 120 capsules per bottle, 60,000 mg total labeled. One active, fully disclosed—ingredient, evidence boundaries, and batch records can all be checked below.
¥268$39.8
美元商品价按中国售价换算 · 运费在结账时单列China-equivalent product price · shipping listed separately at checkout
购买数量Choose quantity
数量微调Adjust
¥268
- 剂型Format
- 胃溶明胶胶囊（0 号）Gastric-soluble gelatin capsule (size 0)
- 每份用量Serving
- 1 粒（500 mg）1 capsule (500 mg)
- 每瓶份数Servings
- 120
- 单一活性成分Single active
- BONTAC® β-NMN · 99.9%
- 不含Free of
- 二氧化钛 · 麸质 · 大豆TiO₂ · gluten · soy
- 产地Origin
- 中国香港 · cGMP 工厂Hong Kong · cGMP facility
以完整成本为基准，当前单瓶毛利率约 30%–35%；规模扩大后继续下压。成本、毛利与价格同步公开。Against fully loaded cost, the current China gross margin is about 30%–35%. As scale grows, we will keep lowering it. Costs, margins, and pricing remain open.
查看成本与定价 →View costs & pricing →公开现有文件，也公开证据缺口；资料关联不冒充当前批投料证明。We disclose available files and evidence gaps; file associations are not presented as current-lot production proof.
核对资料边界 →Inspect evidence limits →产品目标Product purpose
做一款高性价比、剂量清晰的 NMN 单方产品A clearly dosed NMN single-ingredient formula built for long-term value
一粒含 500 mg NMN，每瓶 120 粒，约可补充 4 个月；用清晰剂量与长周期规格，降低日常补充门槛。Each capsule provides 500 mg of NMN; 120 capsules supply about four months of use. Clear dosing and a long-duration format help lower the barrier to a consistent routine.
原料MaterialsBONTAC® 全酶法 β-NMN，纯度与异构体可追溯BONTAC® enzymatic β-NMN with traceable purity and isomer ratio
剂量Dose500 mg/粒落在人体研究常用区间 250–900 mg500 mg/capsule within the common 250–900 mg human-study range
证据Evidence六篇研究与一项 EFSA 监管意见可打开核对Six studies and one EFSA opinion linked for verification
价格Price完整成本公开，规模扩大后继续下压Full cost disclosed; scale should keep lowering markup
应对日常疲倦与状态波动For everyday fatigue and energy dips
NMN围绕 NAD⁺ 前体与细胞能量路径Built around the NAD⁺ precursor path
NMN每日 1 粒、约 4 个月/瓶的稳定补充节奏One capsule daily; about four months per bottle
500 mg / 日500 mg / day只要 NMN 标量、不要多成分协同时选本品；要多路径可看复配页Choose this for NMN dose alone; see the complex for multi-path support
NMN 复方 ↗NMN Complex ↗产品全貌Product at a glance
一种成分，剂量写满标签One active. Dose on the label.
单一 BONTAC® β-NMN 500 mg/粒，无隐藏复配；每瓶 120 粒、标示总量 60,000 mg。Single BONTAC® β-NMN at 500 mg per capsule, no proprietary blend; 120 capsules per bottle, 60,000 mg total labeled.
单一成分1 IN 1
一条 NAD⁺ 前体路径One NAD⁺ precursor path
配方分工Formula role
NAD⁺ 直接前体Direct NAD⁺ precursor
全酶法 β-NMN 经补救合成途径一步转化为 NAD⁺；不叠加甲基供体、线粒体或探索性协同层。Enzymatic β-NMN converts to NAD⁺ in one step on the salvage pathway; no methyl donor, mitochondrial, or exploratory synergy layers.
原料组成Materials
单一活性原料One active material
BONTAC® β-NMN · 99.9% · 全酶法
生产检测Production
香港生产 · 公开资料可核Made in Hong Kong · public records inspectable
当前批次真实性与投料链仍待闭环。Current-lot identity and material linkage remain unresolved.
标准用法Standard use
每日 1 粒 · 120 日 · 约 ¥2.2 / 日1 capsule daily · 120 days · about ¥2.2/day
按单瓶价 ¥268 与标准每日 1 粒计算；可至 2 粒/日（1000 mg）上限。Based on bottle price ¥268 and one capsule daily; up to 2 capsules (1000 mg) as upper limit.
完整配方Complete formula
每日一粒，
单一成分，剂量清晰One capsule.
One active, dose disclosed.
仅一行活性成分：500 mg BONTAC® β-NMN；辅料与每日参考值一并写清，无隐藏复配。One active row: 500 mg BONTAC® β-NMN; excipients and %DV status shown, with no proprietary blend.
补充剂成分表Supplement Facts
活性成分Active ingredient每份含量Amount%参考值%DV
BONTAC® β-NMN全酶法烟酰胺单核苷酸 · 99.9%Enzymatic beta-NMN · 99.9%500 mg†
† 每日摄入参考值尚未确定。† Daily Value (DV) not established.
人体试验常用剂量落在此区间；本品 500 mg/粒可按需每日 1 粒或至多 2 粒（1000 mg），按研究水平添加而非象征性剂量。Human trials commonly use this range; at 500 mg/capsule you may take 1 daily or up to 2 (1000 mg)—dosed to studied levels, not token amounts.
把 NMN 一味做透：不与白藜芦醇、紫檀芪等常被一并营销的「NAD⁺ 复方」混配——这类协同的人体证据多数不足。We do one ingredient thoroughly—no resveratrol, pterostilbene, or other "NAD⁺ stack" actives whose combined human evidence is mostly insufficient.
500 mg × 120 份 = 每瓶标示总量 60,000 mg（电商常见「60000mg」标示）。500 mg × 120 servings = 60,000 mg per bottle (common "60000mg" listing figure).
其他成分：Other ingredients: 微晶纤维素、二氧化硅、胃溶明胶胶囊（0 号）。无隐藏复配；不含二氧化钛、麸质与大豆。Microcrystalline cellulose, silicon dioxide, gastric-soluble gelatin capsule (size 0). No proprietary blends; free of titanium dioxide, gluten, and soy.
配方理念Formula architecture
单一路径：NAD⁺ 前体一层Single path: one NAD⁺ precursor layer
不叠四层复方；只保留 NMN → NAD⁺ 这一条可在人体研究中核对的路径。No four-layer complex—only the NMN → NAD⁺ path verifiable in human research.
NAD⁺细胞能量辅酶cellular coenzyme
BONTAC® β-NMN500 mg · 直接前体direct precursor
01补救合成 → NAD⁺Salvage → NAD⁺
NMN 经 NMNAT 酶一步转化为 NAD⁺；人体 RCT 中血液 NAD⁺ 上升较一致。NMN converts to NAD⁺ in one step via NMNAT; blood NAD⁺ rises most consistently in human RCTs.
A02替代终点 ≠ 健康获益Surrogate ≠ outcome
NAD⁺ 指标变化不等于延寿或功能改善；荟萃分析对血糖、血脂、肌量终点多为阴性或不支持。A change in NAD⁺ is not lifespan or functional proof; meta-analyses are negative or non-supportive for glycemic, lipid, and muscle endpoints.
A03安全与监管Safety & regulation
短期人体研究耐受良好；EFSA 对 β-NMN 作为烟酰胺来源出具安全意见，新食品授权程序尚未完成。Short-term human studies show good tolerance; EFSA issued a safety opinion on β-NMN as a nicotinamide source—the Novel Food authorization is not yet complete.
B / REG成分档案Ingredient profiles
一种成分，
剂量与边界写清One active,
dose and boundaries disclosed
展开查看剂量依据、研究边界；进入 WIKI 阅读完整 NMN 资料。Open for dosage rationale and evidence limits; continue to the WIKI for the full NMN record.
01BONTAC® β-NMNNAD⁺ 前体 · 99.9%NAD⁺ precursor · 99.9%单一活性成分Single active500 mgWIKI ↗
是什么What it is
NAD⁺ 的直接前体；本品仅含这一味活性成分——BONTAC® 全酶法 β 型，纯度 99.9%。A direct NAD⁺ precursor and the sole active in this formula—BONTAC® full-enzymatic β-isomer at 99.9% purity.
为何此剂量Why this dose
500 mg 位于人体试验常用区间 250–900 mg/日；每日 1 粒为标准用量，可至 2 粒（1000 mg）上限。不把动物剂量直接放大成人体承诺。500 mg sits within the common 250–900 mg/day human-study range; 1 capsule is standard, up to 2 (1000 mg) as upper limit. Animal doses are not converted into human promises.
边界Boundary
血液 NAD⁺ 上升较一致，但不等于延寿；体能荟萃非显著、血糖血脂阴性、肌量不支持；整体抗衰人体证据仍稀缺。营销最响的方向，往往是证据最弱的方向。Blood NAD⁺ rises most consistently, but that is not lifespan proof; performance meta-analyses are non-significant, glycemic/lipid outcomes negative, muscle outcomes unsupported; clear human anti-aging evidence remains scarce.
A / B · PMID 36482258 · 39221308 · 39531138 · 40275690 · 37619764 · 31685720
科学证据Evidence ledger
不只列有利研究Not only favorable findings
人体试验、综述、监管意见和阴性结果分级公开；剂量与单方相关性写在上方成分档案；这里只列可核对的研究收据。Human trials, reviews, regulatory opinions, and negative results are graded separately. Dose relevance lives in the ingredient profile above; this section is the verifiable receipt list.
A · 人体系统证据 / RCT / 荟萃B · 小型人体研究 / 综述C · 细胞或动物机制REG · 监管意见
多中心双盲安慰剂对照试验（n=80）：NMN 以剂量相关方式提升全血 NAD⁺。Multicenter double-blind placebo-controlled trial (n=80): NMN raised whole-blood NAD⁺ in a dose-related manner.
GeroScience · 2022 · PMID 36482258NMN 与体能表现：RCT 系统综述（10 项、n=437）——与体力/有氧改善非显著相关，耐受良好。NMN and physical performance: systematic review of RCTs (10 studies, n=437)—non-significant association with physical/aerobic improvement; well tolerated.
Cureus · 2024 · PMID 39221308RCT 系统综述与荟萃分析（n=342）：短期 NMN 未显著改善空腹血糖、胰岛素、HbA1c 或血脂。Systematic review and meta-analysis (n=342): short-term NMN did not significantly improve fasting glucose, insulin, HbA1c, or lipids.
Current Diabetes Reports · 2024 · PMID 39531138骨骼肌质量与功能荟萃（10 项 RCT）：现有证据不支持 NMN/NR 改善肌量、握力或步速。Meta-analysis of skeletal muscle outcomes (10 RCTs): current evidence does not support NMN/NR improving muscle mass, grip, or gait speed.
J Cachexia Sarcopenia Muscle · 2025 · PMID 40275690人体临床试验安全性与「抗衰」效应综述：NMN 耐受良好、能升高 NAD⁺，但明确的人体抗衰效应证据仍稀缺。Review of human trials on safety and "anti-aging" effects: NMN well tolerated and raises NAD⁺, but clear human anti-aging evidence remains scarce.
Advances in Nutrition · 2023 · PMID 37619764首次健康男性单次口服研究：至 500 mg NMN 耐受良好，未见显著临床不良发现。First single-dose study in healthy men: up to 500 mg NMN well tolerated without significant clinical findings.
Endocrine Journal · 2020 · PMID 31685720EFSA 新食品安全科学意见：β-NMN 在拟定条件下作为烟酰胺（维生素 B3）来源安全；新食品授权程序尚未完成。EFSA Novel Food safety opinion: β-NMN safe as a nicotinamide (vitamin B3) source under proposed conditions; authorization procedure not yet complete.
EFSA Journal · DOI 10.2903/j.efsa.2026.10007我们不主张What we do not claim
- 不把它写成疾病治疗方案或「抗衰老治疗」。It is not a disease treatment or "anti-aging therapy."
- 不承诺快速、可感知的效果。No promise of fast, felt effects.
- 不把 NAD⁺ 指标变化等同于延长寿命。A change in NAD⁺ is not proof of longer lifespan.
已知阴性与风险Negative and risk signals
- 体能荟萃：与体力/有氧改善非显著相关。Performance meta-analysis: non-significant association with physical/aerobic improvement.
- 代谢荟萃：血糖、血脂终点为阴性。Metabolic meta-analysis: negative for glycemic and lipid endpoints.
- 肌量荟萃：现有证据不支持功能改善。Muscle meta-analysis: current evidence does not support functional improvement.
我们还没有What we do not yet have
- 本品级长期、大样本人体临床研究——成分研究不能相加成产品结论。A long-term, large human clinical study for this specific product—ingredient studies do not add up to product proof.
- 孕期、哺乳期、儿童及长期合用的充分资料。Adequate evidence for pregnancy, nursing, children, or long-term combined use.
- 更完整的跨批次归档与检索体验。A more complete cross-lot archive and search experience.
孕期、哺乳期、儿童、正在用药或有健康状况者，使用前请咨询专业人士。成分剂量见上方「成分档案」。Seek professional advice before use during pregnancy, nursing, childhood, medication use, or an existing health condition. Dose details are in the ingredient profile above.
适用场景Everyday contexts
为长期 NAD⁺ 日常支持而设计Designed for long-term everyday NAD⁺ support
适合希望单一 NMN 标量、建立稳定补充习惯的成年人。For adults who want a single NMN dose and a steady supplementation routine.
银发长辈Later adulthood关注体力、脑力与日常能量支持Focused on physical, cognitive, and everyday energy support
高压工作High-pressure work工作强度大，白天精力消耗多High workload and sustained daytime demand
作息不稳Irregular rhythm熟夜、作息波动，关注晨间状态Late nights, shifting schedules, and morning-state support
高强度用脑Mental workload长时间脑力工作，关注注意力与日常状态Long cognitive work and everyday attention demands
早期年龄管理Early age management察觉状态变化，希望建立长期日常养护Noticing change and building a long-term routine
主动健康管理Proactive upkeep偏好单一成分、标量清楚与简单用法Prefer one active, a clear dose, and a simple routine
怎么吃How to use
每日份量Daily serving多数成人 1 粒（500 mg）1 capsule (500 mg) for most adults
每日上限Upper limit不超过 2 粒（1000 mg）Do not exceed 2 capsules (1000 mg)
建议时间Timing早或午餐前空腹；胃敏感者餐后Before breakfast/lunch on empty stomach; after meals if sensitive
不适用Not for孕期、哺乳期与儿童未经专业建议不使用Pregnancy, nursing, or children without professional advice
保存Storage阴凉干燥处保存，避免阳光直射Store cool and dry, away from direct sunlight
阶段Stage
可以合理期待Reasonable expectation
不应期待Do not expect
开始使用Starting
建立稳定的每日补充习惯，观察耐受。Establish a consistent routine and observe tolerance.
一两次服用就出现明显体感。A dramatic effect after one or two servings.
持续使用Ongoing use
把它视为长期营养支持的一部分，并结合睡眠、饮食和运动。Treat it as one part of long-term support alongside sleep, diet, and exercise.
替代专业建议，或保证特定健康结果。A replacement for professional advice or a guaranteed health outcome.
产品迭代Product evolution
百吉会持续改进原料、批次公开、价格与信息体验。BIOGEEK will keep improving materials, batch disclosure, pricing, and information access.
每个版本一开始就是终点。That any version is final.
服务边界：Service boundary: 复杂健康与用药问题应交给专业人士；常见高频问题优先用可追溯知识库与 AI 客服回答。Complex health and medication issues belong with qualified professionals; common questions are handled via a traceable knowledge base and AI support.
生产与批次资料Production & lot information
用包装批号，核对这一批产品Use the package lot code to check this production lot
下方并列展示 2025 文件关联与历史批次 LB2240501 资料；两组文件不能互相替代，也不能自动代表当前在售库存。The page displays a 2025 file association alongside historical lot LB2240501 records; the two sets are not interchangeable and do not automatically identify current-sale inventory.
莱可福生产Made by LEKKERFOOD莱可福国际功能食品有限公司 · 香港屯门LEKKERFOOD International Functional Foods · Tuen Mun, Hong Kong
历史批次 LB2240501Historical lot LB22405012024 年 5 月 27 日 · 报告已公开May 27, 2024 · reports published
GMP · ISO 22000 · HACCPSGS 认证 · 有效至 2029 年 6 月 26 日SGS certified · valid through June 26, 2029
香港持牌食品工厂Licensed Hong Kong food factory生产主体、地址与资质均公开Manufacturer, address, and qualifications disclosed
包装批号Package lot codeLB2240501
公开的 BONTAC 原料 COA 与成品 CTI 没有领料/投料记录闭环；CTI 第 2 页把胶囊样品数量写成“片”，取得书面更正前不用于证明剂型或包装数量。成品报告只证明列明样品与 8 项重金属/微生物项目；当前在售批身份仍为 HOLD。No issue record links the public BONTAC raw COA to the finished CTI sample. Page 2 of the CTI report counts the capsule sample as tablets, so it is not used to prove dosage form or pack count without a written correction. The finished report covers only its named sample and eight heavy-metal/microbiology items; current-sale lot identity remains on HOLD.
原料RAW · 1BONTAC® β-NMN 原料 COABONTAC® β-NMN raw-material COA
生产信息PRODUCTION生产企业、批号与产品日期信息Manufacturer, lot code, and product dates
成品报告FINISHED REPORT · 1仅适用于报告样品与列明项目Limited to the named sample and listed analytes
BONTAC® β-NMN COA
优质 · 透明 · 低价Quality · transparency · fair price
原料和成本，同时公开Open materials. Open cost structure.
单瓶成本与售价公开如下。Unit cost and selling price are listed below.
30–35%
当前单瓶毛利率Current gross margin
按包含生产、检测、物流仓储、包装运费、关税及平台费用的完整成本计算。规模扩大后继续下压。Calculated against the full disclosed cost base including production, testing, logistics, packaging, duties, and platform fees. Scale should lower this further.
生产成本Production cost¥85
成品检测费Finished-product testing¥2
物流与仓储Logistics & warehousing¥2.5
包装与运费Packaging & shipping¥30
关税Duties¥35
平台与技术服务费Platform & technology fees¥18
百吉毛利润BIOGEEK gross profit¥75–95
价格Price¥248–268
瓶数1236
每瓶价格¥268¥263¥258¥253
合计¥268¥526¥774¥1518
每瓶节省—¥5¥10¥15
数量阶梯Quantity pricing1 / 2 / 3 / 6 瓶四档；每升一档，每瓶优惠 ¥5Four tiers; each tier saves another ¥5 per bottle
一瓶 60,000 mg ≈ 约 5 瓶常规 12,000 mg 单方，参考总价约 ¥1000 起One bottle at 60,000 mg ≈ about five regular 12,000 mg singles, reference total from ~¥1000
本品（60,000 mg / 瓶）This product (60,000 mg / bottle)¥268
常规 12,000 mg 单方 × 5 瓶Regular 12,000 mg single × 5 bottles≈ ¥1000 起
同类单方价格用于比较，不是实时报价。Comparable single-ingredient prices are for comparison, not live quotes.
八维自评Eight-dimension review
34.5 / 40，也公开少掉的 5.5 分34.5 / 40—with every deduction visible
百吉内部产品评估：配方、原料、价格、安全、透明、体验、信任与创新。BIOGEEK's internal review across formula, materials, value, safety, transparency, experience, trust, and innovation.
34.5/ 40百吉内部自评BIOGEEK INTERNAL REVIEW
产品力Product strengthA
性价比ValueS
百吉内部自评 · 非第三方认证或行业排名。依据八维评估与本页公开的配方、原料、价格和批次资料。BIOGEEK internal review—not a third-party certification or industry ranking. Based on the eight-dimension review and the formula, materials, pricing, and lot records disclosed on this page.
单方仅 NMN 一路径，人体临床仍依赖成分级证据；无复方协同研究层，也不等于更弱，只是评分方式不同。Single-ingredient NMN path only—human clinical evidence still relies on ingredient-level studies; no complex synergy layer, not weaker by design, but scored differently.
1 + 1 文件与历史批次 LB2240501 已公开；跨批次检索与聚合体验仍可改进。The 1 + 1 files and historical lot LB2240501 are public; cross-lot search and aggregation can still improve.
单方产品线官网评价与长期公开记录仍在积累；电商历史反馈尚未完全聚合至本页。Site reviews and long-term public record for this single-ingredient line are still accumulating; marketplace history is not fully aggregated here yet.
单一 NMN 为成熟品类；创新主要在剂量透明、成本公开与诚实阴性证据叙事，尚无专属剂型、递送技术或产品级临床验证。Single NMN is a mature category; innovation here is mainly transparent dosing, open costing, and honest negative-evidence disclosure—no proprietary format, delivery tech, or product-level clinical validation yet.
用户评价Customer reviews
平台历史评价与官网已购评价，分别标明来源Marketplace history and verified site reviews, clearly sourced
电商历史评价保留平台、时间、规格与原始链接；官网评价仅向已完成订单开放。Marketplace reviews retain platform, date, SKU, and source link; site reviews are available only after a completed order.
来自中国电商平台的历史购买反馈。聚合展示时保留平台、购买时间、商品规格与原始链接，正负评价采用同一规则。Historical purchase feedback from China marketplaces. Aggregated entries retain platform, date, SKU, and source link, with one rule for praise and criticism.
评价入口绑定官网订单与具体规格；修改配方、剂型、包装、价格和信息公开方式的建议，会进入产品版本记录。The review entry is tied to a site order and SKU. Feedback on formula, format, packaging, pricing, and disclosure enters the product version record.
购买前Before buying
购买前常见问题Questions before you buy
怎么吃、有没有感觉、能不能抗衰、检测与合规地区，以及批次 1 + 1 怎么查。How to take it, what to expect, anti-aging claims, testing, regional compliance, and how to check the 1 + 1 batch archive.
吃 NMN 真的能抗衰老吗？Does NMN really slow aging?
目前没有充分的人体证据支持「抗衰老治疗」这类说法。可以确定的是：补 NMN 能提升血 NAD⁺（研究较一致），但那是化验指标，距离「活得更久更好」还有很长的因果链——2023 年综述明确指出人体抗衰效应证据仍稀缺。我们把它当作值得继续研究、但远未被人体证据证实的成分如实介绍。There isn't sufficient human evidence for "anti-aging therapy" claims. NMN raises blood NAD⁺ consistently in studies, but that lab marker is a long chain away from "living longer or better"—a 2023 review noted clear human anti-aging evidence remains scarce. We present it as worth continued study, not proven by human evidence.
多久才会有感觉？How long before I notice anything?
体感差异很大——很慢，甚至不一定有明显变化。血液 NAD⁺ 可在数周内上升，但「升了」不等于立刻有感觉。这是需要稳定长期服用的日常养护型产品，不是速效产品；不要期待立竿见影，也不要为追求体感自行加量。Subjective experience varies widely—slowly, and you may feel nothing obvious. Blood NAD⁺ can rise over weeks, but that doesn't equal an immediate sensation. This is for steady long-term upkeep, not a fast fix; don't increase the dose just to chase a feeling.
每天吃几粒，什么时候吃？How many capsules, and when?
多数成人每日 1 粒（500 mg）；可按耐受至 2 粒（1000 mg），不建议更高。建议早或午餐前空腹，胃敏感者餐后。一瓶 120 粒约 4 个月。孕妇、哺乳期与儿童不建议使用。Most adults take 1 capsule (500 mg) daily; up to 2 (1000 mg) if well tolerated—not higher. Take before breakfast/lunch on empty stomach, or after meals if sensitive. One bottle lasts about four months. Not recommended during pregnancy, nursing, or childhood.
如何查看批次检测资料？How do I check batch testing?
先按包装批号核对文件，再阅读适用边界：当前公开原料 COA 与成品报告之间没有投料链；成品 CTI 只覆盖列明的 8 项安全项目，且“片/胶囊”字段仍待书面更正。历史 LB2240501 资料不能替代当前批证据。Match the package lot code to the files, then read their limits: no issue chain links the public raw COA to the finished report; the CTI covers only eight listed safety items and its tablet/capsule wording awaits written correction. Historical LB2240501 records do not replace current-lot evidence.
在中国 / 美国 / 欧洲能合法买到吗？Can I legally buy it in China / the US / Europe?
各地差别很大且一直在变。美国：FDA 2022 年曾裁定 NMN 不属膳食补充剂，2025 年又反转确认合法。中国大陆：NMN 未获批为保健食品或普通食品原料，跨境电商监管身份仍不明朗。欧盟：作为新食品尚在审批，EFSA 2026 年出具正面安全意见但未完成最终授权。使用前请确认所在地最新规定。Rules vary by region and keep changing. US: FDA reversed in 2025 to confirm NMN in dietary supplements. Mainland China: NMN is not approved as a health food or ordinary food ingredient; cross-border status remains unclear. EU: Novel Food review ongoing—EFSA issued a positive 2026 safety opinion but final authorization is incomplete. Confirm local rules before use.
和百吉复配 NMN 怎么选？How is this different from NMN Ultimate Complex?
本品 = 单一 500 mg NMN，适合只要标量、不要多成分协同的人。复配页 = 六种活性成分多路径，适合希望一条配方覆盖更多研究层的人。两条路径各有定位，互不贬低。This product = single 500 mg NMN for those who want dose alone. The complex = six actives and multiple paths for those who want one formula covering more research layers. Both paths serve different needs without dismissing either.
1优质配方 · 单一活性成分完整标量Quality formula · one active, fully listed
6 + 1循证 · 六篇研究与一项监管意见可打开Evidence · six studies and one regulatory opinion linked
HOLD证据边界 · 当前批身份与投料链待补Evidence boundary · current-lot identity and linkage pending
30–35%低价 · 当前单瓶毛利率Low price · current China gross margin
先把事实看清楚，再决定要不要加入购物车。Read the facts first. Then decide whether to add it.
¥268$39.8